• 1. Dissolution of cork biopolymers in biocompatible ionic liquids
  Helga Garcia,Rui Ferreira,Marija Petkovic,Jamie L. Ferguson,Maria C. Leit?o,H. Q. Nimal Gunaratne,Luís Paulo N. Rebelo Green Chem., 2010,12, 367-369
• 2. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696
• 3. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
• 4. Evolution of important glucosinolates in three common Brassica vegetables during their processing into vegetable powder and in vitro gastric digestion
  Nan Fu,Naphaporn Chiewchan,Xiao Dong Chen Food Funct., 2020,11, 211-220
• 5. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Tetracarboxylic acids and derivatives

(S)-1-(p-Bromoacetamidobenzyl)ethylenediaminetetraacetic Acid (CAS No. 81677-64-7): An Overview of a Versatile Chelating Agent

(S)-1-(p-Bromoacetamidobenzyl)ethylenediaminetetraacetic Acid (CAS No. 81677-64-7) is a chelating agent that has garnered significant attention in the fields of chemistry, biochemistry, and pharmaceutical research. This compound, commonly referred to as (S)-BABA-EDTA, is characterized by its unique structural features and versatile applications in various scientific and industrial processes. In this comprehensive overview, we will delve into the chemical properties, synthesis methods, biological activities, and potential applications of (S)-BABA-EDTA.

Chemical Structure and Properties

(S)-1-(p-Bromoacetamidobenzyl)ethylenediaminetetraacetic Acid (CAS No. 81677-64-7) is a chiral compound with a molecular formula of C₁₅H₂₀BrN₃O₆. The molecule consists of an ethylenediaminetetraacetic acid (EDTA) backbone with a substituted p-bromoacetamidobenzyl group attached to one of the nitrogen atoms. The presence of the bromine atom and the amide functionality imparts unique chemical properties to the compound, making it an effective chelating agent for various metal ions.

The chiral center in the molecule is crucial for its biological activity and selectivity. The (S)-configuration of the compound has been shown to exhibit distinct properties compared to its (R)-enantiomer, which can be advantageous in certain applications such as enantioselective catalysis and drug development.

Synthesis Methods

The synthesis of (S)-1-(p-Bromoacetamidobenzyl)ethylenediaminetetraacetic Acid (CAS No. 81677-64-7) involves several steps, starting from commercially available starting materials. One common approach is to react p-bromoacetanilide with ethylenediamine to form the intermediate amide, followed by further functionalization to introduce the EDTA moiety. The chiral center can be introduced through asymmetric synthesis or resolution techniques.

Recent advancements in synthetic chemistry have led to more efficient and environmentally friendly methods for the preparation of chiral compounds like (S)-BABA-EDTA. For instance, the use of organocatalysts and biocatalysts has shown promise in achieving high enantioselectivity and yield in the synthesis process.

Biological Activities and Applications

(S)-1-(p-Bromoacetamidobenzyl)ethylenediaminetetraacetic Acid (CAS No. 81677-64-7) has been studied for its potential biological activities, particularly in metal ion chelation and drug delivery systems. The ability of this compound to form stable complexes with metal ions such as iron, copper, and zinc makes it useful in various biomedical applications.

In the context of drug delivery, (S)-BABA-EDTA can be used as a carrier molecule to enhance the solubility and bioavailability of poorly soluble drugs. By forming complexes with metal ions or other functional groups, it can improve the pharmacokinetic properties of therapeutic agents. This property has been exploited in the development of targeted drug delivery systems for cancer therapy and other diseases.

Additionally, (S)-BABA-EDTA has shown promise in chelation therapy for conditions such as iron overload disorders. Its ability to selectively bind and remove excess iron from the body can help mitigate the toxic effects associated with iron accumulation.

Current Research Trends

The ongoing research on (S)-1-(p-Bromoacetamidobenzyl)ethylenediaminetetraacetic Acid (CAS No. 81677-64-7) is focused on expanding its applications in various fields. One area of interest is its use in nanotechnology for developing novel drug delivery systems. Researchers are exploring the potential of incorporating (S)-BABA-EDTA into nanoparticles to enhance their stability and targeting capabilities.

Another promising application is in environmental remediation. The ability of (S)-BABA-EDTA to form stable complexes with heavy metals makes it a potential candidate for removing toxic metals from contaminated water sources. Studies have shown that this compound can effectively sequester metals such as lead, cadmium, and mercury, making it a valuable tool in environmental cleanup efforts.

In conclusion, (S)-1-(p-Bromoacetamidobenzyl)ethylenediaminetetraacetic Acid (CAS No. 81677-64-7), or (S)-BABA-EDTA, is a versatile chelating agent with a wide range of applications in chemistry, biochemistry, pharmaceuticals, and environmental science. Its unique chemical structure and biological activities make it an important compound for ongoing research and development efforts aimed at addressing various scientific challenges.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)